Literature DB >> 727759

Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.

A W Chow, D Bednorz.   

Abstract

The in vitro susceptibilities of 408 recent clinical isolates of anaerobic bacteria against cefaclor, cephalexin, cephalothin, cefazolin, cefamandole, and cefoxitin were compared by an agar dilution technique. Against gram-positive bacteria, especially peptococci, peptostreptococci, and propionibacteria, cephalexin and cefaclor were significantly less active than cephalothin (P < 0.05). Cephalexin was also less active than cephalothin against clostridia and lactobacillus (P < 0.05). Against gram-negative bacteria, major differences were observed primarily with Bacteroides fragilis, against which cephalexin, cefazolin and cefoxitin were all significantly more active than cephalothin (P < 0.001). At concentrations of 16 mug per ml, however, all cephalosporins showed high in vitro activity, except against Lactobacillus species and B. fragilis. Cephalothin, cefazolin and cefamandole were considerably more active against the former, whereas cefoxitin was distinctly more active against the latter.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727759      PMCID: PMC352532          DOI: 10.1128/AAC.14.5.668

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.

Authors:  A W Chow; V Patten; L B Guze
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

2.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Characterisation of a -lactamase obtained from a strain of Bacteroides fragilis resistant to -lactam antibiotics.

Authors:  J D Anderson; R B Sykes
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

5.  Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.

Authors:  A S Bayer; A W Chow; D Betts; L B Guze
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

6.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Cephalosporinase activity in Bacteroides fragilis.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

  7 in total
  12 in total

Review 1.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Bacteroides fragilis septicemia during cefamandole therapy.

Authors:  J Righter
Journal:  Can Med Assoc J       Date:  1981-09-01       Impact factor: 8.262

3.  Comparison of the activity of ionophores with other antibacterial agents against anaerobes.

Authors:  K Watanabe; J Watanabe; S Kuramitsu; H B Maruyama
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

Authors:  M V Borobio; J Aznar; R Jimenez; F Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.

Authors:  D J Flournoy; F A Perryman
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

8.  Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.

Authors:  G B Hill; O M Ayers
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Cefazolin versus ampicillin/sulbactam as an empiric antibiosis in severe odontogenic neck infection descending from the lower jaw-retrospective analysis of 350 cases.

Authors:  Johannes Buller; Matthias Kreppel; Matthias Zirk; Joachim E Zoeller; Franziska Peters; Linda Ringendahl
Journal:  Clin Oral Investig       Date:  2020-08-10       Impact factor: 3.573

10.  Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.

Authors:  T J Marrie; E V Haldane; C A Swantee; E A Kerr
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.